United States· US:42126-5200_c9c6902a-e7b2-43d6-98bf-ba4131fbaf5a
VISCO SHIELD
A medicinal product containing hypromellose 2208 (15000 mpa.s), registered in United States by OASIS Medical, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HYPROMELLOSE 2208 (15000 MPA.S)
- Manufacturer
- OASIS Medical, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1142126520006 POUCH in 1 CARTON (42126-5200-0) / 1 SYRINGE, PLASTIC in 1 POUCH / 2 mL in 1 SYRINGE, PLASTIC
- ndc1142126-5200-0
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a082d571-6cf0-48cf-a9d5-efacc1b7e3a2 GET /v1/drugs/a082d571-6cf0-48cf-a9d5-efacc1b7e3a2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "17",
"substance": "HYPROMELLOSE 2208 (15000 MPA.S)",
"productndc": "42126-5200",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "M018",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about hypromellose 2208 (15000 mpa.s).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.